Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jenhjackson
    Junior Member
    • Aug 2010
    • 2

    #1

    Cheers from Jen Jackson

    Hi everyone -

    I've been a stalker for a while and now finally a member ...

    In my career, I've been lucky enough to have been working with genomic information and tool packages in both Industry and Academia for [gasp] 16 years.

    Recently, I've started working with the Penn State Galaxy project. I've also been working on and off with UCSC's Genome Browser team for close to 6 years. Before that, I was with Incyte Pharmaceuticals/Genomics/Corporation for 10 years, where we changed our name a lot and I was fortunate enough to be there at the beginning and to turn off the light on my way out of the Palo Alto site.

    I am a hybrid scientist, techie, project/staff manager, and teacher. I'll tell you that I don't code, but that would be a lie, I just don't do it for anyone else. I also do not do active research anymore, which would not be a lie, but I still have pretty strong opinions about what constitutes valid research methods. But, I am great at helping others to do both, which I also think is not a lie, but perhaps you'll all let me know.

    Hopefully, I'll be able to learn a lot and help out a bit where I can.

    Nice to be here!

    jen
    Jennifer Hillman Jackson
    http://usegalaxy.org

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...